You are here:Home1/20062/New anti-cancer drug discovery alliance between GlaxoSmithKline, the Wellcome...
New anti-cancer drug discovery alliance between GlaxoSmithKline, the Wellcome Trust and The Institute of Cancer Research, focused on B-RAF inhibitors, builds on partnership between Astex, the Wellcome Trust, the Institute of Cancer Research and Cancer Res
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2006-07-27 13:54:292016-11-28 13:55:06New anti-cancer drug discovery alliance between GlaxoSmithKline, the Wellcome Trust and The Institute of Cancer Research, focused on B-RAF inhibitors, builds on partnership between Astex, the Wellcome Trust, the Institute of Cancer Research and Cancer Res